The goal of the European PneumoNP project is to develop a theragnostic system for the treatment of pneumonia with gram-negative bacteria. The focus is on the bacterium Klebsiella pneumoniae, which can cause so-called Friedländer pneumonia in persons with weakened immune systems. Theragnostic systems are diagnostic systems with an integrated therapy. The ultimate goal is to be able to use inhalable nano-therapeutics to treat antibiotic-resistant respiratory infections, based on a combination of nanocarriers coupled to new antibiotics.

The EU project will be funded for 4 years and unites research institutes, universities, hospitals and business ventures from 6 European Member States. It is supported by the European Union’s Seventh Framework Programme with 5.7 million euros.

source:
http://www.item.fraunhofer.de/en/press-media/latest-news/pm_pneumonp.html
http://www.pneumonp.eu